Public Notifications

Search

Search Results

Search Again
McRae, Sarah (Oct 10, 2016)

Sarah McRae has completed a term of suspension which ended on October 9, 2016, and her registration as a pharmacist has been reinstated as of October 10, 2016.

September 10, 2016
(October 10, 2016 - Registration Reinstated)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with Sarah McRae (the “Registrant”) to temporarily suspend her registration as a pharmacist for 30 days, effective September 10, 2016 to October 9, 2016.

On March 12, 2015, a pharmacist at the Registrant’s pharmacy dispensed allopurinol to a patient which interacted with her existing medication, azathioprine. The drug-drug interaction between allopurinol and azathioprine is serious and well-known. On April 3, 2015, another pharmacist at the pharmacy dispensed refill prescriptions for allopurinol and azathioprine to the patient. These refills were dispensed again the next month on May 29, 2015 by the Registrant.  In May 2015, the patient began experiencing symptoms of pancytopenia and was admitted to the hospital.  The patient remained in the hospital for 18 days during which she received multiple blood transfusions and required blood tests to determine the cause of her symptoms.

The Inquiry Committee found that the Registrant did not conduct a PharmaNet review, failed to detect the drug-drug interaction and did not provide counselling when she dispensed the medications to the patient.  The Inquiry Committee determined that in the interest of public safety, a 1-month suspension of the Registrant’s licence and educational remediation was appropriate for addressing this incident.  The Registrant has completed her educational requirements to the Inquiry Committee’s satisfaction and is now entering a 30-day suspension period for her licence.  The Inquiry Committee considers this agreement necessary to protect the public.   

Pharmacist Registrant 24 (Aug 12, 2016)

Pharmacist Registrant 24 has satisfied terms of an agreement reached with the Inquiry Committee on April 22, 2016. Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed. The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 17 (Jul 24, 2016)

Pharmacist Registrant 17 has satisfied the terms of an agreement reached with the Inquiry Committee dated July 24, 2016. Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed. The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Buhecha , Nikhil Kantilal (Jul 20, 2016)

The Inquiry Committee received and considered a consent order proposal from Nikhil Kantilal Buhecha (the “Registrant”) prior to the commencement of a hearing into allegations against him, set to proceed before the Discipline Committee on July 18, 2016.  The proposal was made pursuant to section 37.1 of the Health Professions Act.  The Inquiry Committee reviewed the proposal, the allegations against the Registrant set out in the Citation and decided to accept the terms which are now orders pursuant to section 37.1(3)(a) of the Health Professions Act.  The Inquiry Committee considers that the following orders made against the Registrant are consistent with the seriousness of the facts and circumstances set out in the Citation:

  • That the Registrant’s registration as a Full Pharmacist be suspended for a period of three (3) years, to commence on July 20, 2016;
  • That the Registrant pay a $50,000 fine and $100,000 in costs - $75,000 of the total amount to be paid prior to his reinstatement and the remaining $75,000 to be paid no later than one year from date of reinstatement;
  • That the Registrant not be an owner or director of a pharmacy in British Columbia for a period of five (5) years from the date his suspension commences;
  • That prior to reinstatement the Registrant comply with Criminal Records Review Act requirements;
  • That prior to reinstatement the Registrant write a letter to the Inquiry Committee reflecting upon his conduct in this matter and what he has learned; and
  • That prior to reinstatement the Registrant successfully complete Parts 1 and 2 of the Pharmacist Qualifying Exam through the Pharmacy Examining Board of Canada, the College’s Jurisprudence Exam, and the ProBE ethics program.​
Pharmacist Registrant 15 (Jul 15, 2016)

Pharmacist registrant has satisfied the terms of an agreement reached with the Inquiry Committee dated September 18, 2015. Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 29 (Jul 1, 2016)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with pharmacist registrant to suspend his registration as a pharmacist effective July 1, 2016. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The registrant's name has been withheld, pursuant to 39.3(4) of the Health Professions Act.

Sands, Ian Colin (Jun 15, 2016)

Ian Colin Sands has satisfied the terms of an agreement reached with the Inquiry Committee dated June 22, 2015.  Limits and conditions on Ian Colin Sands’ registration have now been removed. 

Singh, Amarjit Kaur (May 25, 2016)

Pursuant to s. 35(4) of the Health Professions Act, the Inquiry Committee has determined that the limits and conditions imposed on the practice of pharmacy on Amarjit Kaur Singh are no longer necessary. Limits and conditions on Amarjit Kaur Singh’s registration have now been removed.

Parkins, Janet Carol (May 17, 2016)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with registrant Janet Carol Parkins to change her registration status to Former Pharmacist and is no longer a registrant of the College.  

On March 12, 2015, the registrant dispensed allopurinol to a patient which interacted with her existing medication, azathioprine. The drug-drug interaction between allopurinol and azathioprine is serious and well-known.  The two medications were refilled (by other pharmacists) for the next two months until the patient began experiencing symptoms of pancytopenia and was admitted to the hospital.  The patient remained in the hospital for 18 days during which she received multiple blood transfusions and required blood tests to determine the cause of her symptoms.

The Inquiry Committee found that the registrant did not conduct a PharmaNet review and failed to detect the drug-drug interaction on one occasion. The registrant provided basic counselling to the patient at the time of releasing the drug but did not alert the patient of the drug-drug interaction.  The Inquiry Committee determined that in the interest of public safety, a 1-month suspension of the registrant’s licence and educational remediation was appropriate for addressing this incident.  In lieu of suspension and remediation, the registrant requested and reached an agreement with the Inquiry Committee to relinquish her licence. If the registrant applies for reinstatement of her licence in the future, she will be required to complete the remediation steps set out by the Inquiry Committee and will be subject to a practice audit.  

Pharmacy Technician Registrant 1 (Apr 24, 2016)

The Inquiry Committee, pursuant to s. 36 of the Health Professions Act, has reached an agreement with the pharmacy technician registrant to voluntarily suspend the registration as a pharmacy technician effective April 24, 2016. The agreement remains in place until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacy technician’s name has been withheld pursuant to section 39.3(4) of the Health Professions Act.

Pages